In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis

Prognostic biomarkers for prostate cancer are needed to improve prediction of disease course and guide treatment decisions. However, biomarker development is complicated by the common multifocality and heterogeneity of the disease. We aimed to determine the prognostic value of candidate biomarkers t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kidd, Susanne G., Bogaard, Mari, Carm, Kristina T., Bakken, Anne Cathrine, Maltau, Aase M. V., Løvf, Marthe, Lothe, Ragnhild A., Axcrona, Karol, Axcrona, Ulrika, Skotheim, Rolf I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348599/
https://www.ncbi.nlm.nih.gov/pubmed/35574900
http://dx.doi.org/10.1002/1878-0261.13225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348599/
https://www.ncbi.nlm.nih.gov/pubmed/35574900
http://dx.doi.org/10.1002/1878-0261.13225

Ejemplares similares